Literature DB >> 28790174

Multiple DNA-binding modes for the ETS family transcription factor PU.1.

Shingo Esaki1, Marina G Evich1, Noa Erlitzki1, Markus W Germann2,3, Gregory M K Poon4,5.   

Abstract

The eponymous DNA-binding domain of ETS (E26 transformation-specific) transcription factors binds a single sequence-specific site as a monomer over a single helical turn. Following our previous observation by titration calorimetry that the ETS member PU.1 dimerizes sequentially at a single sequence-specific DNA-binding site to form a 2:1 complex, we have carried out an extensive spectroscopic and biochemical characterization of site-specific PU.1 ETS complexes. Whereas 10 bp of DNA was sufficient to support PU.1 binding as a monomer, additional flanking bases were required to invoke sequential dimerization of the bound protein. NMR spectroscopy revealed a marked loss of signal intensity in the 2:1 complex, and mutational analysis implicated the distal surface away from the bound DNA as the dimerization interface. Hydroxyl radical DNA footprinting indicated that the site-specifically bound PU.1 dimers occupied an extended DNA interface downstream from the 5'-GGAA-3' core consensus relative to its 1:1 counterpart, thus explaining the apparent site size requirement for sequential dimerization. The site-specifically bound PU.1 dimer resisted competition from nonspecific DNA and showed affinities similar to other functionally significant PU.1 interactions. As sequential dimerization did not occur with the ETS domain of Ets-1, a close structural homolog of PU.1, 2:1 complex formation may represent an alternative autoinhibitory mechanism in the ETS family at the protein-DNA level.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  DNA-binding protein; DNA-protein interaction; ETS transcription factor family; Negative cooperativity; PU.1; nuclear magnetic resonance (NMR); protein-DNA interaction

Mesh:

Substances:

Year:  2017        PMID: 28790174      PMCID: PMC5625037          DOI: 10.1074/jbc.M117.798207

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  Structure-function studies of ETS transcription factors.

Authors:  M Mimeault
Journal:  Crit Rev Oncog       Date:  2000

2.  Base coupling in sequence-specific site recognition by the ETS domain of murine PU.1.

Authors:  Gregory M K Poon; Robert B Macgregor
Journal:  J Mol Biol       Date:  2003-05-09       Impact factor: 5.469

3.  Sequence discrimination by DNA-binding domain of ETS family transcription factor PU.1 is linked to specific hydration of protein-DNA interface.

Authors:  Gregory M K Poon
Journal:  J Biol Chem       Date:  2012-04-02       Impact factor: 5.157

4.  Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages.

Authors:  Yojiro Arinobu; Shin-ichi Mizuno; Yong Chong; Hirokazu Shigematsu; Tadafumi Iino; Hiromi Iwasaki; Thomas Graf; Robin Mayfield; Susan Chan; Philippe Kastner; Koichi Akashi
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

5.  Quantitative hydroxyl radical footprinting reveals cooperative interactions between DNA-binding subdomains of PU.1 and IRF4.

Authors:  P Gross; A A Yee; C H Arrowsmith; R B Macgregor
Journal:  Biochemistry       Date:  1998-07-07       Impact factor: 3.162

6.  1-Anilino-8-naphthalene sulfonate anion-protein binding depends primarily on ion pair formation.

Authors:  D Matulis; R Lovrien
Journal:  Biophys J       Date:  1998-01       Impact factor: 4.033

7.  Epigenomic elements enriched in the promoters of autoimmunity susceptibility genes.

Authors:  Mikhail G Dozmorov; Jonathan D Wren; Marta E Alarcón-Riquelme
Journal:  Epigenetics       Date:  2013-11-08       Impact factor: 4.528

8.  Structural Basis for Dimerization and DNA Binding of Transcription Factor FLI1.

Authors:  Caixia Hou; Oleg V Tsodikov
Journal:  Biochemistry       Date:  2015-12-10       Impact factor: 3.162

9.  Recognition of DNA by p53 core domain and location of intermolecular contacts of cooperative binding.

Authors:  Thomas M Rippin; Stefan M V Freund; Dmitry B Veprintsev; Alan R Fersht
Journal:  J Mol Biol       Date:  2002-05-31       Impact factor: 5.469

10.  Down-regulation of PU.1 by methylation of distal regulatory elements and the promoter is required for myeloma cell growth.

Authors:  Hiro Tatetsu; Shikiko Ueno; Hiroyuki Hata; Yasuhiro Yamada; Motohiro Takeya; Hiroaki Mitsuya; Daniel G Tenen; Yutaka Okuno
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

View more
  3 in total

1.  Identification and characterization of BEND2 as a key regulator of meiosis during mouse spermatogenesis.

Authors:  Longfei Ma; Dan Xie; Mengcheng Luo; Xiwen Lin; Hengyu Nie; Jian Chen; Chenxu Gao; Shuguang Duo; Chunsheng Han
Journal:  Sci Adv       Date:  2022-05-25       Impact factor: 14.957

2.  Mapping interfacial hydration in ETS-family transcription factor complexes with DNA: a chimeric approach.

Authors:  Amanda V Albrecht; Hye Mi Kim; Gregory M K Poon
Journal:  Nucleic Acids Res       Date:  2018-11-16       Impact factor: 16.971

3.  Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients.

Authors:  Carole Le Coz; David N Nguyen; Chun Su; Brian E Nolan; Amanda V Albrecht; Suela Xhani; Di Sun; Benjamin Demaree; Piyush Pillarisetti; Caroline Khanna; Francis Wright; Peixin Amy Chen; Samuel Yoon; Amy L Stiegler; Kelly Maurer; James P Garifallou; Amy Rymaszewski; Steven H Kroft; Timothy S Olson; Alix E Seif; Gerald Wertheim; Struan F A Grant; Linda T Vo; Jennifer M Puck; Kathleen E Sullivan; John M Routes; Viktoria Zakharova; Anna Shcherbina; Anna Mukhina; Natasha L Rudy; Anna C E Hurst; T Prescott Atkinson; Titus J Boggon; Hakon Hakonarson; Adam R Abate; Joud Hajjar; Sarah K Nicholas; James R Lupski; James Verbsky; Ivan K Chinn; Michael V Gonzalez; Andrew D Wells; Alex Marson; Gregory M K Poon; Neil Romberg
Journal:  J Exp Med       Date:  2021-05-05       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.